BISMUTH SUBSALICYLATE TABLETS

The contract award SPE2DP26F7712 issued by the Defense Logistics Agency under the Department of Defense is for the delivery of 3.000 pounds gross of Bismuth Subsalicylate Tablets, identified by NSN 6505014437607 and NDC 00904-7205-46, to Kadena Air Base in Okinawa, Japan. The total contract value is $4.80, with a unit price of $1.60 per pound, and the delivery is scheduled for July 30, 2026, under delivery order SPE2DX25D9900. The awardee, DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0, is responsible for shipping the product FOB Destination, bearing all transportation costs and risks until delivery. Inspection and acceptance occur at the destination with zero tolerance for quantity variance, ensuring exact compliance with the ordered amount. Payment is managed through the FM5270 form, with remittance directed to Kadena AB Building 3154, and accounting tied to Defense Identification Code A01, Fund Code 6B, and Procurement Request 7017513542. The contract is executed under existing DLA logistics frameworks and implicitly follows standard DoD pharmaceutical supply protocols, though no explicit FAR clauses, MIL-STD references, or special requirements such as security clearances, key personnel mandates, or OCI provisions are documented. Packaging, labeling, and barcoding are inferred from the use of standard identifiers like NSN and NDC and compliance with DLA’s FM5270 documentation system, with no additional specifications provided. The solicitation was awarded as a fixed-price single-delivery order with no options, and no socioeconomic, size status, or representation certifications beyond the CAGE code are stated. The point of contact for administrative and invoicing matters is listed as CP 011 81 98 938 1111 EXT 634 4572 under MDSS SGSM, though no individual names or designated COR/COTR roles are provided.